The goal of “closing the gap” in life expectancy between Indigenous and non-Indigenous people by 2030 is probably unattainable.
Despite our best efforts, it is implausible that, within 21 years, preventive strategies, social or medical, will extinguish all excess expression and risk of chronic disease, the greatest contributor to excess Indigenous deaths.
Developing systems to supply optimal primary care, as we currently know it, will take time. In addition, we have an incomplete understanding of the nature of excess risk, and lack remedies to totally contain it. Furthermore, vertical imprinting of excess risk will take some generations to ameliorate.
To avoid failure by specifying unattainable goals, emphasis should be given to process measures that will lead to better outcomes.
It is self-evident that sustained change requires better education, nutrition, employment opportunities and infrastructure.
Within the health system, access to good quality, integrated primary care, needs-based health services funding, and an urgent and intensified focus on areas with the highest mortality rates, are top priorities.
- 1. Close The Gap. Indigenous Health Equality Summit. Statement of intent. March 2008. http://www.hreoc.gov.au/social_justice/health/statement_intent. html (accessed Mar 2009).
- 2. Australian Institute of Health and Welfare. Australia’s health 2008. Canberra: AIHW, May 2008. (AIHW Cat. No. AUS 99.) http://www.aihw.gov.au/publications/index.cfm/title/10585 (accessed Mar 2009).
- 3. Australian Broadcasting Corporation. The 7.30 report. Reporter: Kerry O'Brien. Kerry O'Brien discusses the Government’s plans for Indigenous health equality with Health Minister Nicola Roxon. March 2008. http://www.abc.net.au/7.30/content/2007/s2196074.htm (accessed Mar 2009).
- 4. Altman J, Biddle N, Hunter B. The challenge of “closing the gaps” in Indigenous socioeconomic outcomes. Canberra: Centre for Aboriginal Economic Policy Research, Australian National University, 2008. http://www.anu.edu.au/caepr/ClosingTheGaps.pdf (accessed Mar 2009).
- 5. Australian Institute of Health and Welfare. Rural, regional and remote health: a study in mortality. Rural Health Series, No. 2. Canberra: AIHW, 2003. (AIHW Cat. No. PHE 45.)
- 6. Australian Institute of Heath and Welfare. Rural, regional and remote health: a study on mortality (2nd edition). Rural Health Series, No. 8. Canberra: AIHW, 2007. (AIHW Cat. No. PHE 95.) http://www.aihw.gov.au/publications/phe/rrrh-som-2/rrrh-som-2.pdf (accessed Mar 2009).
- 7. Maori Health. Statistics. Health status indicators. Life expectancy. http://www.maorihealth.govt.nz/moh.nsf/indexma/life-expectancy (accessed Mar 2009).
- 8. Indian Health Service (Grimm CW, Director). Facts on Indian health disparities. http://info.ihs.gov/Files/DisparitiesFacts-Jan2006.pdf (accessed Mar 2009).
- 9. CloseTheGap. Solutions to the Indigenous health crisis facing Australia. A policy briefing paper from the National Aboriginal Community Controlled Health Organisation and OXFAM Australia. April 2007. http://www.ahmrc.org.au/Downloads/CTG.pdf (accessed Mar 2009).
- 10. Daviglus ML, Lloyd Jones DM, Pirzada A. Preventing cardiovascular disease in the 21st century: therapeutic and preventive implications of current evidence. Am J Cardiovasc Drugs 2006; 6: 87-101.
- 11. Daniel M, Rowley KG, McDermott R, et al. Diabetes incidence in an Australian Aboriginal population: an 8-year follow-up study. Diabetes Care 1999; 22: 1993-1998.
- 12. Rowley KG, O’Dea K, Anderson I, et al. Lower than expected morbidity and mortality for an Australian Aboriginal population: 10-year follow-up in a decentralised community. Med J Aust 2008; 188: 283-287. <MJA full text>
- 13. Hoy WE, Wang Z, VanBuynder P, et al. The natural history of renal disease in Australian Aborigines. Part 2. Albuminuria predicts natural death and renal failure. Kidney Int 2001; 60: 249-256.
- 14. Wang Z, Hoy WE. Is the Framingham coronary heart disease absolute risk function applicable to Aboriginal people? Med J Aust 2005; 182: 66-69. <MJA full text>
- 15. Wang Z, Hoy WE. Albuminuria and incident coronary heart disease in Australian Aboriginal people. Kidney Int 2005; 68: 1289-1293.
- 16. Voss T, Barker B, Stanley L, Lopez AD. The burden of disease and injury in Aboriginal and Torres Strait Islander peoples. Summary report. Brisbane: School of Population Health, University of Queensland, 2007. http://www.uq.edu.au/bodce/docs/2MB-Indigenous-BoD-Summary-Report.pdf (accessed Mar 2009).
- 17. Kondalsamy-Chennakesavan S, Hoy WE, Wang Z, Shaw J. Quantifying the excess risk of type 2 diabetes by body habitus measurements among Australian Aborigines living in remote areas. Diabetes Care 2008; 31: 585-586.
- 18. Hoy WE, Mathews JD, McCredie DA, et al. The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community. Kidney Int 1998; 54: 1296–1304.
- 19. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet 2004; 364: 937-952.
- 20. Sayers S, Powers J. Risk factors for Aboriginal low birthweight, intrauterine growth retardation and preterm birth in the Darwin Health Region. Aust N Z J Public Health 1997; 21: 524-530.
- 21. Harris KR, Bucens IK. Prevalence of fetal alcohol syndrome in the Top End of the Northern Territory. J Paediatr Child Health 2003; 39: 528-533.
- 22. Odendaal HJ, Steyn DW, Elliott A, Burd L. Combined effects of cigarette smoking and alcohol consumption on perinatal outcomes. Gynecol Obstet Invest 2009; 67: 1-8.
- 23. Somm E, Schwitzgebel VM, Vauthay DM, et al. Prenatal nicotine exposure alters early pancreatic islet and adipose tissue development with consequences on the control of body weight and glucose metabolism later in life. Endocrinology 2008; 149: 6289-6299.
- 24. Gray SP, Kenna K, Bertram JF, et al. Repeated ethanol exposure during late gestation decreases nephron endowment in sheep. Am J Physiol Regul Integr Comp Physiol 2008; 295: R568-R574.
- 25. Barker DJ. Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283.
- 26. Hoy WE, Kondalsamy-Chennakesavan S, Smith J, et al. The Aboriginal Chronic Disease Outreach Program [Final report, Northern Territory]. http://www.healthinfonet.ecu.edu.au/uploads/resources/3289_aboriginal_chronic_disease_program.pdf (accessed Mar 2009).
- 27. Clough AR. Associations between tobacco and cannabis use in remote Indigenous populations in Northern Australia. Addiction 2005; 100: 346-353.
- 28. Mohsin M, Jalaludin B. Influence of previous pregnancy outcomes and continued smoking on subsequent pregnancy outcomes: an exploratory study in Australia. BJOG 2008; 115: 1428-1435.
- 29. Morgan DK, Whitelaw E. The case for transgenerational epigenetic inheritance in humans. Mamm Genome 2008; 19: 394-397.
- 30. Gluckman PD, Hanson MA. Metabolic disease: evolutionary, developmental and transgenerational influences. Nestle Nutr Workshop Ser Pediatr Program 2005; 55: 17-27.
- 31. Kaati G, Bygren LD, Edvinsson S. Cardiovascular and diabetes mortality determined by nutrition during parents’ and grandparents’ slow growth period. Eur J Hum Genet 2002; 10: 682-688.
- 32. Hoy WE, Rees M, Kile E, et al. Low birth weight and renal disease in Australian Aborigines. Lancet 1998; 352: 1826-1827.
- 33. Singh GR, Hoy WE. The association between birth weight and current blood pressure: a cross-sectional study in an Australian Aboriginal community. Med J Aust 2003; 179: 532-535. <MJA full text>
- 34. Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.
- 35. Sleight P, Pouleur H, Zannad F. Benefits, challenges and registerability of the polypill. Eur Heart J 2006; 27: 1651-1656.
- 36. Hoy WE, Kondalsamy-Chennakesavan S, Wang Z, et al, and the AusDiab Study Group. Quantifying the excess risk for proteinuria, hypertension and diabetes in Australian Aborigines: comparison of profiles in three remote communities in the Northern Territory with those in the AusDiab study. Aust N Z J Public Health 2007; 31: 177-183.
Publication of your online response is subject to the Medical Journal of Australia's editorial discretion. You will be notified by email within five working days should your response be accepted.